This requirement would be met to the extent that excessive prices complicate generic production in the market covered by the patent. Appropriate measures include non-enforcement of the patent, but also the granting of a compulsory license under facilitated procedures, as provided under Article 31 (k), TRIPS Agreement. In case of a competitive market, excessive pricing will only push consumers toward purchasing the competitors’ products. As a general rule, excessive pricing by dominant companies may be considered abusive and thus anti-competitive, opening the possibility to issue a compulsory license under facilitated procedures, as provided by Article 31 (k), TRIPS Agreement.